Does CERTOLIZUMAB PEGOL Cause Hypersensitivity? 7,353 Reports in FDA Database

Q: Does CERTOLIZUMAB PEGOL cause Hypersensitivity?

7,353 reports of Hypersensitivity have been filed with the FDA for CERTOLIZUMAB PEGOL, representing 7.4% of all CERTOLIZUMAB PEGOL adverse event reports.

Q: How dangerous is Hypersensitivity from CERTOLIZUMAB PEGOL?

Of 7,353 reports, 1,544 (21.0%) resulted in death and 2,588 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 7,353 reports of Hypersensitivity have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 7.4% of all adverse event reports for CERTOLIZUMAB PEGOL.

7,353

Reports of Hypersensitivity with CERTOLIZUMAB PEGOL

7.4%

of all CERTOLIZUMAB PEGOL reports

1,544

Deaths

2,588

Hospitalizations

How Dangerous Is Hypersensitivity From CERTOLIZUMAB PEGOL?

Of the 7,353 reports, 1,544 (21.0%) resulted in death, 2,588 (35.2%) required hospitalization, and 1,879 (25.6%) were considered life-threatening.

Is Hypersensitivity Listed in the Official Label?

Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for CERTOLIZUMAB PEGOL.

What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?

Drug ineffective (23,838) Rheumatoid arthritis (17,782) Pain (13,929) Fatigue (11,438) Off label use (10,281) Rash (9,663)